Formation of Amyloids by Aβ-(1-42) on NGF-differentiated PC12 Cells: Roles of Gangliosides and Cholesterol

Journal of Molecular Biology

Volumn 371, Issue 4, 2007, Pages 924-933

  Wakabayashi, Masaki ^a   Matsuzaki, Katsumi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

amyloid protein; cholesterol; gangliosides; NGF differentiation; visualization

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN[1-42]; CHOLESTEROL; COMPACTIN; CONGO RED; GANGLIOSIDE; NERVE GROWTH FACTOR; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL MEMBRANE; CELL STRAIN; CELLULAR DISTRIBUTION; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CYTOTOXICITY; NERVE CELL; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RAT; ANIMAL; DRUG EFFECT; METABOLISM; PROTEIN MOTIF;

RATTUS;

AMINO ACID MOTIFS; AMYLOID; AMYLOID BETA-PROTEIN; ANIMALS; CELL DIFFERENTIATION; CHOLESTEROL; CONGO RED; GANGLIOSIDES; NERVE GROWTH FACTOR; PC12 CELLS; PEPTIDE FRAGMENTS; RATS;

EID: 34547118151     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.06.008     Document Type: Article

References (62)

1. Selkoe D.J. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell Biol. 10 (1994) 373-403
2. Harper J.D., and Lansbury Jr. P.T. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66 (1997) 385-407
3. Lansbury Jr. P.T. Structural neurology: are seeds at the root of neuronal degeneration?. Neuron 19 (1997) 1151-1154
4. Yanagisawa K., Odaka A., Suzuki N., and Ihara Y. GM1 ganglioside-bound amyloid β-protein (Aβ): a possible form of preamyloid in Alzheimer's disease. Nature Med. 1 (1995) 1062-1066
5. Yanagisawa K., and Ihara Y. GM1 ganglioside-bound amyloid β-protein in Alzheimer's disease brain. Neurobiol. Aging 19 (1998) S65-S67
6. Lee S.J., Liyanage U., Bickel P.E., Xia W., Lansbury Jr. P.T., and Kosik K.S. A detergent-insoluble membrane compartment contains Aβ in vivo. Nature Med. 4 (1998) 730-734
7. Morishima-Kawashima M., and Ihara Y. The presence of amyloid β-protein in the detergent-insoluble membrane compartment of human neuroblastoma cells. Biochemistry 37 (1998) 15247-15253
8. Simons K., and Ikonen E. Functional rafts in cell membranes. Nature 387 (1997) 569-572
9. Kawarabayashi T., Shoji M., Younkin L.H., Wen-Lang L., Dickson D.W., Murakami T., et al. Dimeric amyloid β protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 24 (2004) 3801-3809
10. Kakio A., Nishimoto S.I., Yanagisawa K., Kozutsumi Y., and Matsuzaki K. Cholesterol-dependent formation of GM1 ganglioside-bound amyloid β-protein, an endogenous seed for Alzheimer amyloid. J. Biol. Chem. 276 (2001) 24985-24990
11. Kakio A., Nishimoto S., Yanagisawa K., Kozutsumi Y., and Matsuzaki K. Interactions of amyloid β-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Biochemistry 41 (2002) 7385-7390
12. Matsuzaki, K. (2007). Physicochemical interactions of amyloid β-peptide with lipid bilayers. Biochim. Biophys. Acta, In the press.
13. 1-40 peptide in solid-supported lipid bilayers. FEBS J. 273 (2006) 1389-1402
14. Bokvist M., Lindström F., Watts A., and Gröbner G. Two types of Alzheimer's β-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation. J. Mol. Biol. 335 (2004) 1039-1049
15. Lau T.L., Ambroggio E.E., Tew D.J., Cappai R., Masters C.L., Fidelio G.D., et al. Amyloid-β peptide disruption of lipid membranes and the effect of metal ions. J. Mol. Biol. 356 (2006) 759-770
16. Wakabayashi M., Okada T., Kozutsumi Y., and Matsuzaki K. GM1 ganglioside-mediated accumulation of amyloid β-protein on cell membranes. Biochem. Biophys. Res. Commun. 328 (2005) 1019-1023
17. Yanagisawa M., Ariga T., and Yu R.K. Fucosyl-GM1 expression and amyloid-β protein accumulation in PC12 cells. J. Neurosci. Res. 84 (2006) 1343-1349
18. Van Nostrand W.E., Melchor J.P., and Ruffini L. Pathologic amyloid β-protein cell surface fibril assembly on cultured human cerebrovascular smooth muscle cells. J. Neurochem. 70 (1998) 216-223
19. Yamamoto N., Matsuzaki K., and Yanagisawa K. Cross-seeding of wild-type and hereditary variant-type amyloid β-proteins in the presence of gangliosides. J. Neurochem. 95 (2005) 1167-1176
20. Yamamoto N., Fukata Y., Fukata M., and Yanagisawa K. GM1-ganglioside-induced Aβ assembly on synaptic membranes of cultured neurons. Biochim. Biophys. Acta 1768 (2007) 1128-1137
21. Richard J.P., Melikov K., Vives E., Ramos C., Verbeure B., Gait M.J., et al. Cell-penetrating peptides. A re-evaluation of the mechanism of cellular uptake. J. Biol. Chem. 278 (2003) 585-590
22. Wang S.S., Rymer D.L., and Good T.A. Reduction in cholesterol and sialic acid content protects cells from the toxic effects of β-amyloid peptides. J. Biol. Chem. 276 (2001) 42027-42034
23. 1-42 into globular neurotoxins. Biochemistry 42 (2003) 12749-12760
24. Sato S.B., Ishii K., Makino A., Iwabuchi K., Yamaji-Hasegawa A., Senoh Y., et al. Distribution and transport of cholesterol-rich membrane domains monitored by a membrane-impermeant fluorescent polyethylene glycol-derivatized cholesterol. J. Biol. Chem. 279 (2004) 23790-23796
25. Ye L., Morgenstern J.L., Gee A.D., Hong G., Brown J., and Lockhart A. Delineation of positron emission tomography imaging agent binding sites on β-amyloid peptide fibrils. J. Biol. Chem. 280 (2005) 23599-23604
26. Ban T., Hoshino M., Takahashi S., Hamada D., Hasegawa K., Naiki H., and Goto Y. Direct observation of Aβ amyloid fibril growth and inhibition. J. Mol. Biol. 344 (2004) 757-767
27. Zhao H., Tuominen E.K., and Kinnunen P.K. Formation of amyloid fibers triggered by phosphatidylserine-containing membranes. Biochemistry 43 (2004) 10302-10307
28. Sparr E., Engel M.F., Sakharov D.V., Sprong M., Jacobs J., de Kruijff B., et al. Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers. FEBS Letters 577 (2004) 117-120
29. Nishio M., Fukumoto S., Furukawa K., Ichimura A., Miyazaki H., Kusunoki S., et al. Overexpressed GM1 suppresses nerve growth factor (NGF) signals by modulating the intracellular localization of NGF receptors and membrane fluidity in PC12 cells. J. Biol. Chem. 279 (2004) 33368-33378
30. Ivins K.J., Bui E.T., and Cotman C.W. β-amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosis. Neurobiol. Dis. 5 (1998) 365-378
31. Song M.S., Saavedra L., and de Chaves E.I. Apoptosis is secondary to non-apoptotic axonal degeneration in neurons exposed to Aβ in distal axons. Neurobiol. Aging 27 (2006) 1224-1238
32. Gylys K.H., Fein J.A., Yang F., Miller C.A., and Cole G.M. Increased cholesterol in Aβ-positive nerve terminals from Alzheimer's disease cortex. Neurobiol. Aging 28 (2007) 8-17
33. Shvartsman D.E., Gutman O., Tietz A., and Henis Y.I. Cyclodextrins but not compactin inhibit the lateral diffusion of membrane proteins independent of cholesterol. Traffic 7 (2006) 917-926
34. Hoekstra D., and van I.S.C. Lipid trafficking and sorting: how cholesterol is filling gaps. Curr. Opin. Cell Biol. 12 (2000) 496-502
35. Wolozin B. A fluid connection: cholesterol and Aβ. Proc. Natl Acad. Sci. USA 98 (2001) 5371-5373
36. Pappolla M.A., Bryant-Thomas T.K., Herbert D., Pacheco J., Fabra Garcia M., Manjon M., et al. Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology 61 (2003) 199-205
37. Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C.G., and Simons K. Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons. Proc. Natl Acad. Sci. USA 95 (1998) 6460-6464
38. Fassbender K., Simons M., Bergmann C., Stroick M., Lütjohann D., Keller P., et al. Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ 42 and Aβ 40 in vitro and in vivo. Proc. Natl Acad. Sci. USA 98 (2001) 5856-5861
39. Ehehalt R., Keller P., Haass C., Thiele C., and Simons K. Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160 (2003) 113-123
40. Zhou Y., and Richardson J.S. Cholesterol protects PC12 cells from β-amyloid induced calcium disordering and cytotoxicity. Neuroreport 7 (1996) 2487-2490
41. Kawahara M., Kuroda Y., Arispe N., and Rojas E. Alzheimer's β-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line. J. Biol. Chem. 275 (2000) 14077-14083
42. Arispe N., and Doh M. Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AβP (1-40) and (1-42) peptides. FASEB J. 16 (2002) 1526-1536
43. Sponne I., Fifre A., Koziel V., Oster T., Olivier J.L., and Pillot T. Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of amyloid-β peptide. FASEB J. 18 (2004) 836-838
44. Isobe I., Michikawa M., and Yanagisawa K. Enhancement of MTT, a tetrazolium salt, exocytosis by amyloid β-protein and chloroquine in cultured rat astrocytes. Neurosci. Letters 266 (1999) 129-132
45. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., and Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300 (2003) 486-489
46. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
47. 1-42 are potent central nervous system neurotoxins. Proc. Natl Acad. Sci. USA 95 (1998) 6448-6453
48. Hartley D.M., Walsh D.M., Ye C.P., Diehl T., Vasquez S., Vassilev P.M., et al. Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19 (1999) 8876-8884
49. Hayashi H., Kimura N., Yamaguchi H., Hasegawa K., Yokoseki T., Shibata M., et al. A seed for Alzheimer amyloid in the brain. J. Neurosci. 24 (2004) 4894-4902
50. Yamamoto N., Matsubara E., Maeda S., Minagawa H., Takashima A., Maruyama W., et al. A ganglioside-induced toxic soluble Aβ assembly. Its enhanced formation from Aβ bearing the Arctic mutation. J. Biol. Chem. 282 (2007) 2646-2655
51. 1-42 oligomer-a homogenous and stable neuropathological protein in Alzheimer's disease. J. Neurochem. 95 (2005) 834-847
52. Johansson A.S., Garlind A., Berglind-Dehlin F., Karlsson G., Edwards K., Gellerfors P., et al. Docosahexaenoic acid stabilizes soluble amyloid-β protofibrils and sustains amyloid-β-induced neurotoxicity in vitro. FEBS J. 274 (2007) 990-1000
53. Grutzendler J., Helmin K., Tsai J., and Gan W.B. Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer's disease. Ann. NY Acad. Sci. 1097 (2007) 30-39
54. Tsai J., Grutzendler J., Duff K., and Gan W.B. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nature Neurosci. 7 (2004) 1181-1183
55. Lorenzo A., and Yankner B.A. Amyloid fibril toxicity in Alzheimer's disease and diabetes. Ann. NY Acad. Sci. 777 (1996) 89-95
56. Jana A., and Pahan K. Fibrillar amyloid-β peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease. J. Biol. Chem. 279 (2004) 51451-51459
57. Petkova A.T., Leapman R.D., Guo Z., Yau W.M., Mattson M.P., and Tycko R. Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science 307 (2005) 262-265
58. Okada, T., Wakabayashi, M., Ikeda, K. & Matsuzaki, K. (2007). Formation of toxic fibrils of Alzheimer's amyloid β-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component. J. Mol. Biol. In press.
59. Zhang Y., McLaughlin R., Goodyer C., and LeBlanc A. Selective cytotoxicity of intracellular amyloid β peptide1-42 through p53 and Bax in cultured primary human neurons. J. Cell Biol. 156 (2002) 519-529
60. Matsuzaki K., Noguch T., Wakabayashi M., Ikeda K., Okada T., Ohashi Y., et al. Inhibitors of amyloid β-protein aggregation mediated by GM1-containing raft-like membranes. Biochim. Biophys. Acta 1768 (2007) 122-130
61. Hasegawa K., Yamaguchi I., Omata S., Gejyo F., and Naiki H. Interaction between Aβ(1-42) and Aβ(1-40) in Alzheimer's β-amyloid fibril formation in vitro. Biochemistry 38 (1999) 15514-15521
62. Kiyokawa E., Baba T., Otsuka N., Makino A., Ohno S., and Kobayashi T. Spatial and functional heterogeneity of sphingolipid-rich membrane domains. J. Biol. Chem. 280 (2005) 24072-24084